EPAM Q1 2026 Earnings EPS Beats Estimates Stock Edges Higher Amid Cautious Outlook ORMP Q4 2025 Earnings Surprise Profit Beats Zero Estimate as Biotech Advances Pipeline HNNA Q1 2026 Earnings Asset Manager Posts 024 EPS as Stock Climbs Nearly 2 Super Group SGHC Q1 2026 Earnings EPS Misses Estimates as Costs Weigh on Results Lantheus Q1 2026 Earnings Strong EPS Beat Driven by Radiopharmaceutical Momentum GEOS Q1 2026 Earnings Losses Reported Stock Edges Lower COYA Q1 2026 Earnings EPS Beat Provides Silver Lining as Revenue Remains Absent SLG Q1 2026 Earnings EPS Misses Amid Market Volatility Stock Rises on Operational Resilience ADP Q1 2026 Earnings EPS Beat Amidst Steady Demand for HCM Solutions CYTK Q1 2026 Earnings Narrower Loss Boosts Investor Confidence but Stock Falters HLMN Q1 2026 Earnings EPS Misses Estimates Stock Gains on Resilient Demand PRTA Q1 2026 Earnings EPS Surges 27169 Above Estimates Despite No Revenue Stock Edges Lower INVH Q1 2026 Earnings EPS Surpasses Estimates by 42 Driving Modest Stock Gains